REPORT OF THE SECOND MEETING OF THE OIE AD HOC GROUP ON DISEASES OF CAMELIDS Paris, 3 5 May 2010
|
|
- Blaise Bates
- 6 years ago
- Views:
Transcription
1 Original: English May 2010 REPORT OF THE SECOND MEETING OF THE OIE AD HOC GROUP ON DISEASES OF CAMELIDS Paris, 3 5 May Opening and purpose of the meeting The second meeting of the OIE ad hoc Group on Diseases of Camelids was held in Paris from 3 to 5 May Dr Kazuaki Miyagishima, Deputy Director General of the OIE and Head of the Scientific and Technical Department, welcomed the participants. He emphasised the strategic importance for the OIE and its Biological Standards Commission to address diseases of camelids, and mentioned that, for this second meeting, the Group would have to continue its work on important issues such as determining priority diseases, setting up a network of laboratories for diseases of camelids and enhancing, where relevant, the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Terrestrial Manual) by including specific requirements for camelids. 2. Designation of chairperson and rapporteur The meeting was chaired by Dr Mehdi El Harrak, and Dr Bernard Faye acted as rapporteur. 3. Adoption of the Agenda and Terms of Reference The Agenda adopted, List of Participants, and Terms of Reference are presented in Appendices I, II and III of this report, respectively. 4. Updating of the list of diseases of interest for Camelids drafted during the first meeting of the ad hoc Group During the Second ISOCARD 1 Conference held in Djerba, Tunisia, in March 2009, the list proposed by the ad hoc Group during its first meeting in July 2008 had been presented by Dr El Harrak. Proposals were made by some participants of the Group to complete this list. Since the first meeting, a lot of new data had also been collected. This second meeting provided an opportunity to update the list of diseases of interest for camelids. The updated list of diseases is presented in Appendix IV. The major discussion and changes are summarised below: The diseases were still presented in a list divided into three categories: Viral diseases, Bacterial diseases and Parasitic and Fungal diseases (this last category initially included Parasitic diseases only). For each category, the diseases were listed by family of camelids (dromedary camels, bactrian camels and New World camelids) and classified into three groups for each of these families with Group I: Known to produce significant diseases, Group II: diseases for which camelids are potential pathogen carriers, and Group III: Minor diseases. 1 International Society of Camelid Research and Development Biological Standards Commission/September
2 The Group agreed that multifactorial diseases (e.g. neonatal diarrhoea, respiratory disease complex, mastitis and sudden mortality syndrome) could be included in the list. However, as these diseases were caused by different aetiological bacteria (e.g. Escherichia coli, Streptococcus sp., Staphylococcus aureus), viral (e.g. rotavirus, coronavirus) or fungal (e.g. Candida sp.) agents and as the recommendations to diagnose or control these diseases were not specific to camelids, they were finally not added to the list. The Group agreed that for these diseases, a holistic approach (ecopathology) should be adopted including risk factors and different aetiologies. For the three categories and each family of camelids, diseases were added, deleted or moved from one group to another, and information was updated when relevant. For the category Viral diseases, the Group recalled that it had removed foot and mouth disease (FMD) from dromedary camels and New World camelids as they were not susceptible while bactrian camels were susceptible to FMD. However this finding would need to be further investigated with regard to the serotypes involved and the role of camelids as potential carriers. Further research would therefore be necessary, especially on diagnostic techniques (NSP tests 2 and 3 ) and for the identification of virus receptors. The Group recommended that if tests were carried out on suspected samples, two different NSP tests be used to avoid as far as possible false positives. Influenza A infections were added to Group I of viral diseases for bactrian camels based on a scientific publication (Yamnikova et al. [1993]. A reassortant H1N1 influenza A virus caused fatal epizootics among camels in Mongolia. Virology., 197(2), ). For the category Bacterial diseases, the Group agreed that Brucellosis appeared to be one of the most important bacterial diseases of camelids (caused mainly by Brucella abortus for bactrian camels contrary to dromedary camels and New World camelids where B. melitensis is predominant). Dermatophilosis was added to Group I of bacterial diseases for dromedary camels. For the category Parasitic and Fungal diseases, gastrointestinal parasitoses were added to Group I for dromedary and bactrian camels as these diseases, caused by several different s (Trichostrongylus, Haemonchus, Taenia etc.) have a significant economic impact. For the same reason, ring worm was added to Group I of parasitic and fungal diseases for the dromedary and bactrian camels and to Group III for the New World camelids. Coccidioidomycosis (emerging fungal disease) was added to Group III for New World camelids. 5. Update on the current disease situation with regards to camelids worldwide, diseases of priority for validation of diagnostic assays and the need for research in diseases of camelids A round table was organised to provide the OIE with a list of the main diseases of camelids according to the different regions of the world. The regions described were the Middle East (with the exclusion of the Gulf countries) (Dr Bengoumi), North and West Africa (Dr El Harrak), Eastern Africa (Dr Khalafalla), the Gulf countries (Dr Wernery) and South Asia for dromedary camels (Dr Gahlot); Central Asia for bactrian camels mainly (Dr Faye); and South America for small camelids (Dr De Lamo). Viral diseases: North and West Africa, and the Middle East: camelpox, Rift Valley fever (RVF), bluetongue (BT) and peste des petits ruminants (PPR). Eastern Africa: camelpox, PPR-like, contagious ecthyma and papillomatosis. Gulf countries: camelpox, ecthyma, BT, bovine viral diarrhea (BVD) and rabies. South Asia: camelpox, rabies, infectious bovine rhinotracheitis (IBR) and PPR. Central Asia: camelpox, rabies, FMD in bactrian camels and influenza. South America: BVD, Equine Rhinopneumonitis (EHV 1 and 4), BT and rotavirus. 2 Nonstructural protein tests 3 Competitive enzyme-linked immunosorbent assay 2 Biological Standards Commission/September 2010
3 Bacterial diseases: North and West Africa, and the Middle East: brucellosis caused by B. melitensis, caseous lymphadenitis, salmonellosis and colibacillosis. Eastern Africa: brucellosis, enterotoxemia, dermatophilosis and caseous lymphadenitis. Gulf countries: clostridiosis, enterotoxemia, brucellosis, paratuberculosis, lymphadenitis, tuberculosis (TB), salmonellosis and colibacillosis. South Asia: brucellosis, caseous lymphadenitis, tuberculosis, haemorrhagic septicaemia (pasteurellosis), enterotoxemia, salmonellosis, Q fever, paratuberculosis, leptospirosis and rickettsia diseases. Central Asia: TB, brucellosis and salmonellosis. South America: enterotoxemia, colibacillosis, brucellosis and TB. Parasitic and Fungal diseases: North and West Africa, and Middle East: trypanosomosis, mange, gastrointestinal s and tick infestations. Eastern Africa: mange, trypanosomosis, ring worm (dermatophytosis) and gastrointestinal s. Gulf countries: mange, ring worm (dermatophytosis), coccidiosis and gastrointestinal s. South Asia: mange, ticks, trypanosomosis and gastrointestinal s. Central Asia: gastrointestinal s, mange, cephalopinosis and fleas. South America: sarcocystosis, echinococosis, coccidiosis and mange. All these diseases required more research and the Group discussed research priorities (infection trials, diagnostic tests, vaccine development, drug resistance etc.) according to the importance of some of these diseases (economic impact, public health, high morbidity and/or mortality, trade constraints) at the global level. After discussion, ten diseases were retained: emerging diseases (PPR, BT, RVF), contagious ecthyma, BVD (in small camelids), brucellosis, enterotoxemia, TB (bactrian and small camelids), mange and tick infestations. Research to be carried out for these diseases was detailed in the columns recommendations for diagnosis and recommendations for prevention of the list developed for the diseases of interest for camelids (Appendix IV). 6. Consideration on the setting up of an OIE laboratory network on diseases of camelids linked with already existing networks on this topic The Group agreed on the need to set up a network of laboratories for diseases of camelids with the main objective of exchanging information and validating diagnostic tests that were currently used for the significant diseases in other species for the different species of camelids. The Group suggested that Dr El Harrak act as the coordinator of this laboratory network. Three types of laboratories would be included: OIE Reference Laboratories for the diseases of interest, associated research laboratories (e.g. Biopharma in Morocco, Central Veterinary Research Laboratory in Dubaï and Brucella Vaccine Centre in Saudi Arabia) and laboratories in camel-rearing countries that were first in line to collect data and samples in the field. The countries to be involved would be, but not limited to, Argentina, Chad, Chile, China (People s Rep. of), Djibouti, Ethiopia, India, Iran, Kazakhstan, Kenya, Mauritania, Mongolia, Pakistan, Peru, Saudi Arabia, Sudan, Syria, Tunisia, Turkmenistan, the USA and Yemen. Contacts would be made with the OIE Delegates during the General Session by Dr El Harrak. The Group would encourage twining projects between OIE Reference Laboratories and National Laboratories from camelid-rearing countries with the potential to support the other National Laboratories in their region. Biological Standards Commission/September
4 The Group suggested that the OIE encourage the representatives of camel-rearing countries (OIE Delegates) to facilitate the shipment of samples from their national laboratories to OIE Reference Laboratories for validation of diagnostic assays, surveillance programmes or when outbreaks occur. However it noted the high costs of such shipments and wondered if specific and sustainable funds (international organisations, donors etc.) could be made available to support such shipment as had been done recently for example with the shipment of avian influenza samples. 7. Review of the disease-specific chapters of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals for the diseases of interest for Camelids The Group reviewed the list of the disease-specific chapters in the Terrestrial Manual to identify the chapters that address diseases of concern for camelids with the aim of verifying if the chapters would need to include specific requirements for diagnostic assays or vaccine production for camelids. Noting that brucellosis (B. abortus and B. melitensis), PPR, TB and BVD were listed as bovidae diseases, as ovidae/capridae diseases or under both, the Group proposed that these four chapters be reviewed for potential inclusion of specific requirements for camelids. The chapters selected and the names of the participants of the Group responsible for this review are detailed below. The Group would provide the results of this review by mid-june to the OIE Headquarters and the Biological Standards Commission. Dr Bengoumi: brucellosis; Dr De Lamo: BVD; Dr El Harrak: BT and West Nile fever; Dr Faye: trypanosomosis and mange; Dr Gahlot: TB and mange; Dr Khalafalla: PPR; and Dr Wernery: coccidiosis, trypanosomosis, FMD and Rift Valley fever. 8. Other matters The Group agreed that a review article on FMD in camelids be proposed for publication by OIE (e.g. in a plurithematic issue of the OIE Scientific and Technical Review). A virtual forum might be implemented in the future for the participants of this Group (Dr Wernery as leader on this project) allowing them to exchange relevant scientific information. A similar forum might be implemented for the laboratory network described above (Dr El Harrak as a leader of this project). The Group had been requested by the OIE ad hoc Group on Brucellosis to review the report of its last meeting. The Group agreed on the need to draft a chapter on Brucellosis for camelids in the Terrestrial Animal Health Code, but also noted the need to do the same for the Terrestrial Manual. The Group suggested that Dr Bengoumi, on behalf of the Group, would participate in the forthcoming meeting of the ad hoc Group on Brucellosis that would be held in July It also suggested the names of experts who could be interested in attending this meeting. The Group would make comments and prepare a common position on Brucellosis in Camelids to be presented by Dr Bengoumi to the forthcoming meeting of the ad hoc Group on brucellosis. The Group proposed having a third meeting of the Group in due time to review the results of the important research programmes mentioned in this report being carried out in the coming months. /Appendices 4 Biological Standards Commission/September 2010
5 Appendix I MEETING OF THE OIE AD HOC GROUP ON DISEASES OF CAMELIDS Paris, 3 5 May 2010 Agenda 1. Opening and purpose of the meeting; 2. Designation of rapporteur; 3. Adoption of the Agenda and Terms of Reference; 4. Updating of the List of diseases of interests for Camelids drafted during the first meeting of the ad hoc Group; 5. Update on the current disease situation with regards to camelids worldwide, diseases of priority for validation of diagnostic assays and the need for research in diseases of camelids; 6. Consideration on the setting up of an OIE laboratory network on diseases of camelids linked with already existing networks on this topic; 7. Review of the disease-specific chapters of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals for the diseases of interest for Camelids; 8. Other matters; 9. Finalisation and adoption of the draft report. Biological Standards Commission/September
6 Appendix II MEETING OF THE OIE AD HOC GROUP ON DISEASES OF CAMELIDS Paris, 3 5 May 2010 List of participants MEMBERS Dr Mehdi El Harrak (Chairperson) Biopharma Chef Département Virologie Avenue Hassan II, km2 BP 4569, Rabat-Akkari MOROCCO Tel: (+212) Fax: (+212) elharrak_m@hotmail.com Dr Mohammed Bengoumi Animal Production & Health Officer FAO/RNE- Regional Office for the Near East 11 Al Eslah Al Zerai St., Dokki P. O. Box PC 12311, Cairo EGYPT Tel : (ext 2806) Direct line: Mobile : Fax: E.mail: mohammed.bengoumi@fao.org; mbengoumi@gmail.com Dr Bernard Faye CIRAD ES ta c-dir/b Campus international Baillarguet Montpellier Cedex 5 FRANCE Tel: (+33-[4]) Fax: (+33-[4]) faye@cirad.fr Dr Abdelmalik Khalafalla Head, Camel Research and Development Program Arab Center for Studies on Arid Zones and Dry Lands (ACSAD) P.O. Box 2440 Damascus SYRIA Tel: Fax: abdokhlf@yahoo.co.uk Dr Ulrich Wernery Scientific Director Central Veterinary Research Laboratory PO Box 597, Dubai UNITED ARAB EMIRATES Tel: (+971) Fax: (+971) wernery@cvrl.ae Dr Daniel de Lamo Prof. Asociado Regular Fisiología General Facultad de Ciencias Naturales UNPSJB - Sede Puerto Madryn Alte. Brown Puerto Madryn, Chubut ARGENTINA Tel: + 54 (0) Fax: +54 (0) delamodan@gmail.com; delamo@cenpat.edu.ar Dr Tarun Kumar Gahlot Head, Department of Veterinary Surgery and Radiology College of Veterinary and Animal Science S.K.Rajasthan Agricultural University Bikaner Rajasthan State INDIA Tel: / Fax: tkcamelvet@yahoo.com OIE HEADQUARTERS Dr Bernard Vallat Director General 12 rue de Prony Paris FRANCE Tel: (33 (0)1) Fax: (33 (0)1) oie@oie.int Dr Kazuaki Miyagishima Deputy Director General k.miyagishima@oie.int Dr François Diaz Officer in charge of the Secretariat for Validation, Certification and Registry of Diagnostic Assays Scientific and Technical Department f.diaz@oie.int 6 Biological Standards Commission/September 2010
7 Appendix III MEETING OF THE OIE AD HOC GROUP ON DISEASES OF CAMELIDS Paris, 3 5 May 2010 Terms of Reference Update the list of diseases of camelids proposed by the ad hoc Group during its first meeting, taking into account any recent publications and the ISOCARD (International Society of Camelid Research and Development) Conference held in Djerba, Tunisia, in March 2009; Determine the diseases of priority for validation of diagnostic assays and the need for research in this area; Review the disease-specific chapters of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals for the diseases that concern Camelids in view of adding, if necessary, specific requirements for diagnostic assays and vaccine production, and propose an outline for these revisions and a timetable to draft them; Provide an update on the current disease situation with regards to camelids worldwide; Consider setting up an OIE laboratory network on diseases of camelids linked with already existing networks on this topic. Biological Standards Commission/September
8 Appendix IV INFECTIOUS DISEASES OF INTEREST FOR CAMELIDS As updated at the second meeting of the OIE ad hoc Group on Diseases of Camelids (May 2010) A) Viral diseases in camelids Group I = Known to produce significant diseases Group II = Diseases for which camelids are potential pathogen carriers Group III = Minor diseases Dromedary camels Diseases Identification of the agent Camelpox Chapter 2.9.2, TEM, virus isolation, IHC and Contagious ecthyma Papillomatosis Serological tests Group I for diagnostic An kit has been developed but still needs to be validated TEM, IHC and Virus isolation is necessary for prevention Vaccination vaccine development TEM, and IHC Autogenous Vaccination Rabies Chapter , FAT and IHC RVF Chapter , Culture, AGID, and Histopathology AHS Chapter , Virus isolation,, and VN Group II 1. Validation of an on more samples would be necessary 2. and duration of viraemia 1. Investigation of for virulent strains and serotypes 2. Investigation of duration of viraemia 3. an Vaccination with cattle dose. However the vaccination protocol needs to be investigated vaccination BT Chapter 2.1.3, Virus isolation, immunological methods and Investigation of for virulent strains and serotypes, and carrier states 1. Investigation for vaccination. 2. Application of the trade measures used for bovines 8 Biological Standards Commission/September 2010
9 BVD Chapter 2.4.8, Virus isolation,, IHC and PPR Chapter , Virus isolation, AGID and Group III 1. Validation of in milk 2. Virus isolation needed should be validated 2. for virulent strains CCHF Virus isolation** and 1. Validation of ruminant 2. Serological survey Herpesvirus Infections West Nile Fever Chapter (EHV), Chapter (IBR),, virus isolation and Immunofluorescence Chapter , and virus isolation 1. Validation of 2. for EHV 4 and BHV 1 for the two strains vaccination using horse protocol *need to work in BSL3 level lab security; **need to work in BSL4 level lab security Bactrian camels Diseases Identification of the agent Camelpox Chapter 2.9.2, TEM, virus isolation, IHC and Contagious ecthyma Serological tests Group I for diagnostic An method has been developed but still needs to be validated for prevention Vaccination. A protocol need to be investigated TEM and IHC Virus isolation vaccine development FMD Chapter , and virus isolation Influenza A infections Virus isolation, and NSP HI 1. Double check with NSP 2. More investigations needed Investigations on the for the different serotypes need to be done Vaccination. A protocol need to be investigated vaccination using horse protocol Biological Standards Commission/September
10 Rabies Chapter , FAT and IHC Vaccination with cattle dose. However the vaccination protocol need to be investigated Group II BVD Chapter 2.4.8, Virus isolation,, IHC and 1. Validation of 2. Group III BT Chapter 2.1.3, Virus isolation, immunological methods and CCHF Herpesvirus Infections Virus isolation** Chapter (EHV), Chapter (IBR),, virus isolation and Immunofluorescence Investigation of for virulent strains and serotypes, and carrier states 1. Validation of ruminant 2. Serological survey 1. Validation of 2. for EHV 1, EHV 4 and BHV 1 1. Investigation for vaccination 2. Application of the trade measures used for bovines vaccination using horse protocol New World camelids Diseases Identification of the agent Serological tests for diagnostic for prevention Group I BVD Chapter 2.4.8, Virus isolation,, IHC and BT Chapter 2.1.3, Virus isolation, immunological methods and Herpesvirus Infections Chapter (EHV), Chapter (IBR),, virus isolation and Immunofluorescence Validation of Investigation of for virulent strains and serotypes 1. Validation of necessary 2. for EHV 1 and BHV 1 vaccination using bovine protocol 1. Vaccination using sheep protocol 2. Application of the trade measures used for bovines vaccination 10 Biological Standards Commission/September 2010
11 Contagious ecthyma Camelpox Chapter 2.9.2, TEM, virus isolation, IHC and Equine encephalomye litis Group II TEM and IHC Virus isolation vaccine development Chapter and Chapter , and virus isolation Rabies Chapter , FAT and IHC West Nile fever & other Flaviviruses Chapter , and virus isolation Group III An kit has been developed but still needs to be validated Validation of available serological tests Vaccination protocol need to be investigated b) Bacterial diseases in camelids Group I = Known to produce significant diseases Group II = Diseases for which camelids are potential pathogen carriers Group III = Minor diseases Dromedary camels Diseases Identification of the agent Anthrax OIE Terrestrial Manual 2008 Chapter , Immunofluorescence,, culture and identification of Bacillus anthracis Brucellosis (B. melitensis) Clostridia infections Chapter , Staining methods, culture and Isolation and typing of bacteria and detection of toxins Serological tests Group I for diagnostic for prevention 1. Vaccination in endemic area 2. Need for vaccine field trial CF, RBT, SAT, and tests available for toxinotyping (perfringens). CF, RBT, SAT and c- need to be validated multiplex 1. Vaccination 2. Vaccination protocols need to be investigated vaccination Biological Standards Commission/September
12 Colibacillosis Chapter , Culture, immunological method and Dermatophilosis (Dermatophilus congolensis) Haemorrhagic septicaemia (Pasteurella multocida or Mannheimia hemolytica) Johne s disease Pyogenic diseases (Caseous lymphadenitis) Chapter , Culture, immunological methods and Chapter , Culture and Chapter , Culture and Isolation and typing of bacteria Salmonellosis Chapter , Culture and Leptospirosis Chapter , Q fever Chapter , Staining, isolation of the agent and Tuberculosis Chapter , Direct identification, culture and Chlamydiosis Glanders (Melioidosis) Plague (Yersiniosis) Isolation and identification of the agent Chapter , Culture and Group II MAT CF RT test Group III CF most pathogenic biovars 2. necessary Identification of the most pathogenic strains Controversial data on and aetiology which need therefore also to be investigated Validation of serological test for Corynebacterium pseudotuberculosis and Staphylococcus aureus most prevalent biovars and investigation on 2. most prevalent biovars Validation of Investigation should be conducted with serological test. Need of further investigation on skin test Validation of Validation of Isolation of bacteria serological test Protocol for vaccination needs to be investigated Eradication of seropositive animals after validation of the tests Eradication of positive animals after validation of the tests Eradication of seropositive animals Eradication of infected animals 12 Biological Standards Commission/September 2010
13 Bactrian camels Diseases Identification of the agent Anthrax OIE Terrestrial Manual 2008 Chapter , Immunofluorescence,, culture and identification of Bacillus anthracis Brucellosis (B. abortus and B. melitensis) Clostridia infections Chapter , Staining methods, culture and Isolation and typing of bacteria and detection of toxins Colibacillosis Chapter , Culture and Johne s disease Plague (Yersiniosis) Pyogenic diseases (Caseous lymphadenitis) Chapter , Culture and Serological tests Group I for diagnostic for prevention 1. Vaccination in endemic area 2. Need for vaccine field trial CF, RBT, SAT, and tests available for toxinotyping (perfringens). CF, RBT, SAT and c- need to be validated for B. abortus and B. melitensis. Tests also need to be validated. multiplex most pathogenic biovars 2. necessary Validation of Isolation of bacteria serological test Isolation and typing of bacteria Salmonellosis Chapter , Culture and Tuberculosis Chapter , Direct identification, culture and RT test serological test for Corynebacterium pseudotuberculosis and Staphylococcus aureus most prevalent biovars and investigation on Investigation should be conducted with serological test 2. skin test 1. Vaccination according to the species (B. abortus or B. melitensis) 2 Vaccination protocols need to be investigated vaccination Eradication of seropositive animals after validation of the tests 1. Eradication of infected animals 2 Control of vectors Eradication of positive animals after validation of the tests Biological Standards Commission/September
14 Group II Leptospirosis Chapter , Q fever Chapter , Staining, isolation of the agent and MAT CF most prevalent biovars Validation of Group III Glanders (Melioidosis) Chlamydiosis Haemorrhagic septicaemia (Pasteurella multocida or Mannheimia hemolytica) Chapter , Isolation and identification of the agent Chapter , Culture and CF Validation of Validation of Eradication of seropositive animals New World camelids Diseases Identification of the agent Anthrax OIE Terrestrial Manual 2008 Chapter , Immunofluorescence,, culture and identification of Bacillus anthracis Brucellosis (B. melitensis) Chapter , Staining methods, culture and Colibacillosis Chapter , Culture and Enterotoxaemia Isolation and typing of bacteria Leptospirosis Chapter , Salmonellosis Chapter , Culture, immunological methods and Serological tests Group I for diagnostic for prevention 1. Vaccination in endemic area 2. Need for vaccine field trial CF, RBT, SAT, and tests available for toxins identification MAT CF, RBT, SAT and c- need to be validated most pathogenic biovars 2. necessary multiplex Identification of the most prevalent biovars and investigation on Identification of the most prevalent biovars 1. Vaccination 2. Vaccination protocols need to be investigated Protocol for vaccination needs to be investigated with available toxoid bacteria 14 Biological Standards Commission/September 2010
15 Tuberculosis Chapter , Direct identification, culture and RT test Tuberculin testing does not work. Serological tests should be developed Eradication of positive animals after validation of the tests Group II Johne s disease Pyogenic diseases (internal abscesses) Chapter , Culture and Isolation and typing of bacteria Q fever Chapter , Staining, isolation of the agent and CF Validation of serological test for Corynebacterium and Staphylococcus Validation of Eradication of seropositive animals after validation of the tests Group III Actinobacillos sis Pasteurellosis (Haemorrhagic septicaemia) Isolation and identification of the agent Chapter , Culture and Validation of c) Parasitic and Fungal diseases in camelids Group I = Known to produce significant diseases Group III = Minor diseases Dromedary camels Diseases Cephalopina infestation Coccidiosis Gastro intestinal parasitosis Hydatidosis Echinococcosis Identification of the agent Serological tests for diagnostic Group I Direct agent identification Identification of the Direct agent identification: Eimeria, Isospora and Cryptosporidium in young camels Direct agent identification: Trichostrongylosis, Haemonchus, Taenia, etc Chapter 2.1.4, Direct agent identification, Coproantigen tests and 2. would be useful Identification of the can be used with anti-camel conjugates for prevention Research for new treatment Research for new treatment and development of treatment protocol and drugs resistance 1. Treatment of the dogs 2. vaccine Biological Standards Commission/September
16 Mange (Sarcoptes scabiei) Ring Worm (Dermatophyt osis) Tick infestations Chapter 2.9.8, Direct agent identification Identification of the for differential diagnosis from other skin diseases (Psoroptes, Ring Worm, etc.) 1. Quarantine and efficient drug for treatment 2. vaccine Direct agent identification Agent identification Vaccines available (initially for bovines) but protocol for the vaccination need to be validated Direct agent identification Identification of the Trypanosomosis Chapter 2.4.8, Myasis other than Cephalopina CATT and Indirect (Neither is commercially available) Group III 1. Indirect can be used with anti-camel conjugates 2. Direct agent identification Identification of the Neosporosis Direct agent identification Serological assay by. Development of would be useful Toxoplasmosis Chapter , Isolation, tissue sections,, Oocyst detection SAT treatment protocols and vaccine 1. Systematic control for trade 2. Treatment of positive animal 3. Need of investigation on the resistance to drugs Avermectines vaccine Bactrian camels Diseases Cephalopina infestation Coccidiosis Gastro intestinal parasitosis Identification of the agent Serological tests Group I for diagnostic Direct agent identification Identification of the Direct agent identification: Eimeria, Isospora and Cryptosporidium in young camels Direct agent identification: Trichostrongylosis, Haemonchus, Taenia, etc 2. would be useful Identification of the for prevention Research for new treatment Research for new treatment and development of treatment protocol and drugs resistance 16 Biological Standards Commission/September 2010
17 Hydatidosis Echinococcosis Mange (Sarcoptes scabiei) Ring Worm (Dermatophyto sis) Ticks infestation Chapter 2.1.4, Direct agent identification, Coproantigen tests and Chapter 2.9.8, Direct agent identification can be used with anti-camel conjugates Identification of the for differential diagnosis from other skin diseases (Psoroptes, Ring Worm, etc.) 1. Treatment of the dogs 2. vaccine 1. Quarantine and efficient drug for treatment 2. Development of vaccine Direct agent identification Agent identification Vaccines available (initially for bovines) but protocol for the vaccination need to be validated Direct agent identification Identification of the Trypanosomosis Chapter 2.4.8, Myasis other than Cephalopina CATT and Indirect (Neither is commercially available) Group III 1. Indirect can be used with anti-camel conjugates 2. Direct agent identification Identification of the Neosporosis Serological assay by. would be useful Toxoplasmosis Chapter , Isolation, tissue sections,, Oocyst detection New World camelids SAT treatment protocols and vaccine 1. Systematic control for trade 2. Treatment of positive animal 3. Need of investigation on the resistance to drugs Avermectines Diseases Identification of the agent Serological tests for diagnostic for prevention Group I Coccidiosis Hydatidosis Echinococcosis Direct agent identification: Eimeria, Isospora and Cryptosporidium in young animals Chapter 2.1.4, Direct agent identification, Coproantigen tests and 2. would be useful can be used with specific conjugates Research for new treatment and development of Treatment of the dogs. Development of vaccine Biological Standards Commission/September
18 Mange (Sarcoptes scabiei) Neosporosis Chapter 2.9.8, Direct agent identification IF Identification of the for differential diagnosis from other skin diseases (psoroptes, Ring Worm, etc.) Sarcocystosis Agent identification An needs to be validated Trematodosis Indirect agent identification only for Fasciola hepatica Coccidioidom ycosis Ring Worm (Dermatophyto sis) Direct agent identification (post mortem) Group III CF and AGID Identification of the large and small trematodes in post mortem Quarantine and good drug for treatment vaccine Evaluation of available vaccine vaccine Treatments. Protocol needs to be validated Treatments available Direct agent identification Agent identification Vaccines available (initially for bovines) but protocol for the vaccination need to be validated List of Abbreviations: Ab-: AHS: BHV: BT: BVD: CATT: CCHF: : CF: CIRAD: CVRL: EHV: FAT FMD: HI: IBR/IPR: IHC: MAT: NSP : OIE: OIE Terrestrial Manual: : PPR: RBT: RVF: SAT: TEM: VNT: Antibody enzyme-linked immunosorbent assay African horse sickness Bovine herpesvirus Bluetongue Bovine viral diarrhoea Card-agglutination trypanosoma test Crimean Congo haemorrhagic fever Competitive enzyme-linked immunosorbent assay Complement fixation Centre de Coopération Internationale pour la Recherche Agronomique en Développement Central Veterinary Research Laboratory (Dubai, UAE) Equine herpesvirus Fluorescent antibody test Foot and mouth disease Heamaglutination inhibition Infectious bovine rhinotrachitis/infectious pustular vulvovaginitis Immunohistochemistry Microscopic agglutination test Nonstructural protein enzyme-linked immunosorbent assay World Organisation for Animal Health OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals Polymerase chain reaction Peste des petits ruminants Rose-Bengal test Rift Valley fever Sero-agglutination test Transmission electron microscopy Virus neutralisation test 18 Biological Standards Commission/September 2010
SIGNIFICANT DISEASES OF CAMELIDAE. Serological tests
Appendix IV (contd) AHG-Camelidae /July 2008 Appendix IV A) Viral diseases in camelids SIGNIFICANT DISEASES OF CAMELIDAE = Significant diseases I = for which camelids are potential pathogen carriers =
More informationA LABORATORY NETWORK FOR DIAGNOSTIC OF CAMELIDS DISEASES
A LABORATORY NETWORK FOR DIAGNOSTIC OF CAMELIDS DISEASES M. EL HARRAK Chair of OIE ad hoc Group on Camelids Diseases Biopharma Lab BP 4569 Rabat Morocco CAMELIDS FAMILY Dromadary Camel Bactrian Camel Lama
More informationOIE laboratory network on diseases of camelids Final report
1 Expert workshop OIE laboratory network on diseases of camelids Final report Teramo, Italy. October, 21-22, 2011 International Training Centre for Veterinary Training and Information Francesco Gramenzi
More informationMAIN PATHOLOGIES OF CAMELS, BREEDING OF CAMELS,
MAIN PATHOLOGIES OF CAMELS, BREEDING OF CAMELS, CONSTRAINTS, BENEFITS AND PERSPECTIVES Conf. OIE 2011, El Harrak et al. M. El Harrak 1, B. Faye 2, M. Bengoumi 3 Original: English Summary: The dromedary
More informationInfectious diseases of camelids
Dr Mehdi EL HARRAK DVM PhD Chairman of OIE Ad Hoc Group on Diseases of Camelids Infectious diseases of camelids CAMENET MEETING ABU DHABI Nov 2017 Ad-hoc group OIE on Camel Diseases Establishment of the
More informationDiseases of Small Ruminants and OIE Standards, Emphasis on PPR. Dr Ahmed M. Hassan Veterinary Expert 7 9 April, 2009 Beirut (Lebanon)
Diseases of Small Ruminants and OIE Standards, Emphasis on PPR Dr Ahmed M. Hassan Veterinary Expert 7 9 April, 2009 Beirut (Lebanon) 1 Small ruminants are very important for: both the subsistence and economic
More informationTerrestrial and Aquatic Manuals and the mechanism of standard adoption
Dr Patrick Bastiaensen Programme Officer OIE Sub-Regional Representation for Eastern Africa Terrestrial and Aquatic Manuals and the mechanism of standard adoption Presented during the Regional Workshop
More informationAnimal health certification in Livestock Trade between the Somalia and the Middle East
Animal health certification in Livestock Trade between the Somalia and the Middle East Presented at Enhancing Safe Inter-Regional Livestock Trade Samaya Hotel UAE by Dr Peter Maina Ithondeka PhD, MBS Director
More informationMATTILSYNET NORWEGIAN FOOD SAFETY AUTHORITY
MATTILSYNET NWEGIAN FOOD SAFETY AUTHITY Referencenumber: N O - COUNTRY: 1.Consignor (Exporter): Name: Address: 2. Certificate reference number: 3. Veterinary Authority: 4. Import permit number: 5. Consignee
More informationMATTILSYNET THE NORWEGIAN FOOD SAFETY AUTHORITY
MATTILSYNET THE NWEGIAN FOOD SAFETY AUTHITY SANITARY CERTIFICATE For export of bovine semen from Norway to New Zealand COUNTRY: 1.Consignor (Exporter): Name: Address: Reference number: 2. Certificate reference
More informationImport Health Standard. For. Bovine Semen
Import Health Standard For Bovine Semen Short Name: bovsemid.gen MAF Biosecurity New Zealand Ministry of Agriculture and Forestry P.O Box 2526 Wellington 6011 New Zealand BOVSEMID.GEN 27 June 2011 Page
More informationActivities of the OIE Regional Representation for the Middle East. Dr. Ghazi Yehia OIE Regional Representative for the Middle East
Activities of the OIE for the Middle East Dr. Ghazi Yehia OIE Regional Representative for the Middle East Paris, 25 27 October 2011 Activities of the OIE RR ME activities Report on the activities and work
More informationPeste des Petits Ruminants
Peste des Petits Ruminants Articles of the OIE Terrestrial Code related to PPR Joseph Domenech Workshop on PPR prevention and control in the SADC Region 10-12 June 2013 Dar es Salam Tanzania The role of
More informationFAO-APHCA/OIE/USDA Regional Workshop on Prevention and Control of Neglected Zoonoses in Asia July, 2015, Obihiro, Japan.
FAO-APHCA/OIE/USDA Regional Workshop on Prevention and Control of Neglected Zoonoses in Asia 15-17 July, 2015, Obihiro, Japan Dr Gillian Mylrea 1 Overview What is a Neglected Zoonotic Disease? The important
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Animal and Plant Health Agency Quality Assurance Unit The Elms, College Road, Sutton Bonington, Loughborough Leicestershire LE12 5RB Contact:
More information21st Conference of the OIE Regional Commission for Europe. Avila (Spain), 28 September 1 October 2004
21st Conference of the OIE Regional Commission for Europe Avila (Spain), 28 September 1 October 2004 Recommendation No. 1: Recommendation No. 2: Recommendation No. 3: Contingency planning and simulation
More informationProtocol between the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China and the
Protocol between the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China and the Federal Agency for the Safety of the Food Chain of the Kingdom of
More informationPeste des Petits Ruminants. Articles of the OIE Terrestrial Manual and Terrestrial Code related to PPR. Joseph Domenech, OIE
Peste des Petits Ruminants Articles of the OIE Terrestrial Manual and Terrestrial Code related to PPR Joseph Domenech, OIE 5 th meeting of the GF TADs Regional Steering Committee for Europe October 8 th
More informationOutlines of Key Funds for Animal Health from Chinese Ministries and in CAAS. Prof. Dr. Hong Yin
Outlines of Key Funds for Animal Health from Chinese Ministries and in CAAS Prof. Dr. Hong Yin Sponsors of Programmes on Animal Health - State level - Ministry of Science and Technology (MOST) - National
More informationOIE Strategy for Veterinary Products and Terms of Reference for the OIE National Focal Points
OIE Strategy for Veterinary Products and Terms of Reference for the OIE National Focal Points Dr Elisabeth Erlacher-Vindel, Deputy Head of the Scientific and Technical Department OIE Strategy for Veterinary
More information2012 Work Programme of the
French Agency for Food, Environmental & Occupational Health Safety Maisons-Alfort LABORATOIRE DE SANTE ANIMALE ANIMAL HEALTH LABORATORY Unité Zoonoses Bactériennes Bacterial Zoonoses Unit 5 August, 2011
More informationOIE Collaborating Centres Reports Activities
OIE Collaborating Centres Reports Activities Activities in 2016 This report has been submitted : 2017-01-12 14:46:21 Title of collaborating centre: Quality Control of Veterinary Vaccines Address of Collaborating
More informationPPR Situation in the Middle East
Ghazi Yehia OIE Regional Representation for the Middle East PPR Situation in the Middle East 13 th Joint Permanent Committee of the REMESA 3-4 November 2016, Byblos,Lebanon Contents PPR background in the
More informationThe OIE-PVS: a tool for good Governance of Veterinary Services
Dr. Alejandro Thiermann President, Terrestrial Animal Health Code Commission World Organisation for Animal Health The OIE-PVS: a tool for good Governance of Veterinary Services Global Animal Health Initiative
More informationOIE Collaborating Centres Reports Activities
OIE Collaborating Centres Reports Activities Activities in 2016 This report has been submitted : 2017-01-20 17:44:12 Title of collaborating centre: Maladies infectieuses de la reproduction en Europe Address
More informationRole and responsibility of Animal Health Research Institute in the national veterinary infrastructure. Dr. Abdel-khalik M.
Role and responsibility of Animal Health Research Institute in the national veterinary infrastructure Dr. Abdel-khalik M. montasser Chief researcher Brucella Department, AHRI e-mail: montasser100@hotmail.com
More information( ) Page: 1/8 COMMUNICATION FROM THE WORLD ORGANISATION FOR ANIMAL HEALTH (OIE)
14 March 2017 (17-1466) Page: 1/8 Committee on Sanitary and Phytosanitary Measures Original: English/French/Spanish 68 TH MEETING OF THE SPS COMMITTEE COMMUNICATION FROM THE WORLD ORGANISATION FOR ANIMAL
More informationThe role of veterinary research institute in improvement of camels health and exportation ABSTRACT
The role of veterinary research institute in improvement of camels health and exportation Ahmed, Elghali A. 1* and M. Zein M. Eisa 2 1 Veterinary Research Institute (VRI), Soba, Khartoum, Sudan. 2 Tumbool
More informationREPORT OF THE MEETING OF THE OIE AD HOC
Original: English May 2018 REPORT OF THE MEETING OF THE OIE AD HOC GROUP ON PRIORITISATION OF DISEASES FOR WHICH VACCINES COULD REDUCE ANTIMICROBIAL USE IN CATTLE, SHEEP, AND GOATS 1 Paris, 7-9 May 2018
More informationQ^- The Notifiable Animal Diseases Order, The Notifiable Animal Diseases Order/ 2018b is revoked. 19 MAR 2019
GREFFE ROYAL COURT 19 MAR 2019 Q^- GUERNSEY STATUTORY INSTRUMENT 2019 No. 3 $ GUERNSEY The Notifiable Animal Diseases Order, 2019 Made Coming into operation Laid before the States 18th March, 2019 18th
More informationOIE policies and approaches to equine health and movement Dr Monique Eloit
OIE policies and approaches to equine health and movement Dr Monique Eloit Deputy Director, OIE Paris Regional Conference for the Middle East and North Africa: Facilitation of International Competition
More informationCOMMON VETERINARY (VETERINARY AND HEALTH) REQUIREMENTS IN RELATION TO GOODS SUBJECT TO VETERINARY CONTROL (INSPECTION)
COMMON VETERINARY (VETERINARY AND HEALTH) REQUIREMENTS IN RELATION TO GOODS SUBJECT TO VETERINARY CONTROL (INSPECTION) Approved by Decision of the Customs Union Commission No 317 of 18 June 2010 (as amended
More informationTTX - Inject 1: Early warning indicators Part I. Regional Table Top Exercise for Countries of Middle East and North Africa Tunisia; July 2017
TTX - Inject 1: Early warning indicators Part I Regional Table Top Exercise for Countries of Middle East and North Africa Tunisia; 11 13 July 2017 Background Information The following takes place in YOUR
More informationREPORT OF THE MEETING OF THE OIE SCIENTIFIC COMMISSION FOR ANIMAL DISEASES. Paris, 7 11 September 2015
Original: English September 2015 REPORT OF THE MEETING OF THE OIE SCIENTIFIC COMMISSION FOR ANIMAL DISEASES Paris, 7 11 September 2015 A meeting of the OIE Scientific Commission for Animal Diseases (the
More informationVeterinary Expenditures
Bilateral Screening Veterinary Expenditures Ministry of Agriculture and Environmental Protection Veterinary Directorate Brussels 20 24 October 2014 CONTENT Legal basis Funding of measures for prevention
More informationRR/SRR annual meeting
Activities of the OIE RR ME 2013 2014 RR/SRR annual meeting Paris 22 26 /10/2013 Ghazi YEHIA Regional Representative Summary: In 2012/2013 the RR was working on the organization of the 12 th Regional
More informationThe OIE Manual of Diagnostic Tests and Vaccines for Terrestrial & Aquatic Animals
The OIE Manual of Diagnostic Tests and Vaccines for Terrestrial & Aquatic Animals Regional seminar for OIE National Focal Points for Veterinary Products, Tokyo, Japan, 3-5 December 2014 Barbara Freischem,
More informationMandate of OIE Reference Centres Capacity Building Support and Networking
1/ 76 30mn Mandate of OIE Reference Centres Capacity Building Support and Networking Regional Seminar on the OIE Laboratory Twinning Programme: Concepts and Perspectives Johannesburg, South Africa, 9-10
More informationNational Import Export Services Overview
National Import Export Services Overview National Equine Health Forum January 19, 2016 Ellen Buck DVM Equine Import Specialist USDA APHIS Veterinary Services Veterinary Services Organization 2 Role of
More informationOIE global strategy for rabies control, including regional vaccine banks
Inception meeting of the OIE/JTF Project for Controlling Zoonoses in Asia under the One Health Concept OIE global strategy for rabies control, including regional vaccine banks Tokyo, Japan 19-20 December
More informationREPORT OF THE MEETING OF THE OIE AD HOC GROUP ON PORCINE CYSTICERCOSIS. Paris (France), 4 6 February 2014
OIE ad hoc Group on Porcine Cysticercosis/February 2014 339 Annex XXXVII Original: English February 2014 REPORT OF THE MEETING OF THE OIE AD HOC GROUP ON PORCINE CYSTICERCOSIS Paris (France), 4 6 February
More informationFAO Initiatives and Protocols on Brucellosis and Tuberculosis Prevention and Control in Animals
FAO Initiatives and Protocols on Brucellosis and Tuberculosis Prevention and Control in Animals Sean V. Shadomy, DVM, MPH, DACVPM FAO Animal Health Service CDC One Health Office Liaison to FAO Outline
More informationOIE international standards on Rabies:
Regional cooperation towards eradicating the oldest known zoonotic disease in Europe Antalya, Turkey 4-5 December 2008 OIE international standards on Rabies: Dr. Lea Knopf Scientific and Technical Department
More information5 west Asian Countries
Dr Ghazi Yehia OIE Regional Representation for the Middle East FMD Situation in the Middle East, Regional Action Plan Stages of FMD Control Progress in 5 west Asian Countries EGYPT- IRAQ- JORDAN- LEBANON-
More informationStructure of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals
Structure of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals Regional Seminar for OIE National Focal Points for Veterinary Laboratories Jeju, Republic of Korea, 5-7 April 2016 Dr.
More informationof Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014
of Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014 2 12 th Conference of the OIE Regional Commission for the Middle East Amman (Jordan),
More informationAU-IBAR s recent past and ongoing Regional initiatives for the Management of TADs & Zoonoses
African Union Interafrican Bureau for Animal Resources AU-IBAR s recent past and ongoing Regional initiatives for the Management of TADs & Zoonoses Seminar on : Rift Valley fever: Challenge, Prevention
More informationOIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2017-01-13 10:41:13 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Enzootic
More informationANNEX. to the. Commission Implementing Decision
EUROPEAN COMMISSION Brussels, 2.5.2017 C(2017) 2841 final ANNEX 1 ANNEX to the Commission Implementing Decision on the adoption of the multiannual work programme for 2018, 2019 and 2020 for the implementation
More informationReport of the Working Group on Wildlife. William B. Karesh, DVM
Report of the Working Group on Wildlife William B. Karesh, DVM Current Composition of the Working Group on Wildlife Dr William B. Karesh(United States of America) (Chairman) Dr John Fischer (United States
More informationFinal Technical Report on the Proposal PGTF- INT/11/K07, PROG/2011/172.
Final Technical Report on the Proposal PGTF- INT/11/K07, PROG/2011/172. PROJECT code: 0007927 A Proposal to Enhance the Capacity Building/Development on the Effect of Climate Change on Animal Health Issues
More informationOverview of the OIE Laboratory Twinning Programme
Overview of the OIE Laboratory Twinning Programme Background Of the current 180 Members Countries of the OIE, 70% are developing or in-transition countries; - with variable scientific capacity and access
More informationDr. Gérard Moulin Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE
Dr. Gérard Moulin Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products BP 90203-35302 FOUGERES CEDEX, FRANCE gerard.moulin@anses.fr Overview of VICH Global outreach initiatives and potential
More informationOffice International des Épizooties World Organisation for Animal Health created in 1924 in Paris
Office International des Épizooties World Organisation for Animal Health created in 1924 in Paris The Challenge of International Biosecurity and the OIE Standards and Actions Meeting of the State Parties
More informationOIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2015 This report has been submitted : 2016-02-03 11:54:54 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Enzootic
More informationACTIVITIES OF THE WORLD ORGANISATION FOR ANIMAL HEALTH (OIE) RELATED TO BEE HEALTH
ACTIVITIES OF THE WORLD ORGANISATION FOR ANIMAL HEALTH (OIE) RELATED TO BEE HEALTH OIE Symposium on emerging infectious agents in honey bees and OIE-listed diseases 2 October 2017, Istanbul, TURKEY Dr
More informationTerrestrial and Aquatic Manuals and mechanism of standard adoption
Regional Seminar OIE National Focal Points for Veterinary Products Entebbe, Uganda, 1 3 December 2015 Terrestrial and Aquatic Manuals and mechanism of standard adoption Dr Francois Diaz Scientific and
More informationOIE SCIENTIFIC COMMISSION FOR ANIMAL DISEASES AND THE OIE TERRESTRIAL ANIMAL HEALTH STANDARDS COMMISSION
OIE SCIENTIFIC COMMISSION FOR ANIMAL DISEASES AND THE OIE TERRESTRIAL ANIMAL HEALTH STANDARDS COMMISSION ISSUES OF INTEREST TO THE REGION CHALLENGES AND PROPOSALS Gideon Brückner President OIE Scientific
More informationBackground 1 st, 2 nd and 3 rd FAO-APHCA/OIE Regional Workshop on Brucellosis Diagnosis and Control with an Emphasis on Brucella melitensis (in
Background 1 st, 2 nd and 3 rd FAO-APHCA/OIE Regional Workshop on Brucellosis Diagnosis and Control with an Emphasis on Brucella melitensis (in collaboration with DLD) Brucellosis OIE Twinning Laboratory
More informationThe OIE Terrestrial and Aquatic Animal Health Codes
OIE Focal Point Seminar on Veterinary Products Vienna, Austria, November 20-22 2012 The OIE Terrestrial and Aquatic Animal Health Codes N. Leboucq OIE sub-regional Representative in Brussels 1 OIE s International
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal viscera, examination of, in investigation of emerging infectious diseases of food animals, 6 American Veterinary Medical Association,
More informationOVERSEAS MARKET ACCESS REQUIREMENTS NOTIFICATION - ANIMAL PRODUCTS ACT 1999 MAF BIOSECURITY NEW ZEALAND
OVERSEAS MARKET ACCESS REQUIREMENTS NOTIFICATION - ANIMAL PRODUCTS ACT 1999 MAF BIOSECURITY NEW ZEALAND Ref: AE-PE 24/11L Date: 30 June 2010 OMAR B OACSEMEC.PER 30.06.10 - OVINE AND CAPRINE SEMEN to PERU
More informationGlobal capacity for sustainable surveillance of emerging zoonoses
IOM, June 2008 Washington, DC Alejandro B Thiermann President, Terrestrial Animal Health Code Commission World Organization for Animal Health Global capacity for sustainable surveillance of emerging zoonoses
More informationTexas A&M Veterinary Medical Diagnostic Laboratory Your One Health Partner. Bruce L. Akey DVM MS Interim Director
Texas A&M Veterinary Medical Diagnostic Laboratory Your One Health Partner Bruce L. Akey DVM MS Interim Director Vision and Mission Vision To be the global leader in providing innovative and state-of-the-art
More informationInvolvement of Europe in the Global Strategies and Coordination with other regions
Mereke Taitubayev Sub-Regional Representative, Kazakhstan Laure Weber-Vintzel Head of the Status Department Involvement of Europe in the Global Strategies and Coordination with other regions 27 th Conference
More informationOIE Standards (Terrestrial and Aquatic Codes and Manuals) and the Role of the Specialist Commissions
Regional Workshop: Training of OIE National Focal Points for Wildlife Bali, Indonesia, 4 6 July 2017 OIE Standards (Terrestrial and Aquatic Codes and Manuals) and the Role of the Specialist Commissions
More informationFESASS General Assembly, 22 September 2011, Brussels. Financial aspects of infectious animal disease control and eradication
Financial aspects of infectious animal disease control and eradication Presentation overwiew Basic information on administrative division & demographics Structure of the Polish Veterinary Services Animal
More informationOIE Collaborating Centre for Training in. Integrated Livestock and Wildlife Health and Management, Onderstepoort. Development of the Centre
OIE Collaborating Centre for Training in Integrated Livestock and Wildlife Health and Management, Onderstepoort Development of the Centre Consortium Partner Institutions Proposal - OIE Collaboration Centre
More informationActivities of the Terrestrial Animal Health Standards Commission Dr Etienne BONBON
Activities of the Terrestrial Animal Health Standards Commission Dr Etienne BONBON Agenda Introduction Member Countries comments Update of Code Commission s work programme New or revised Code texts proposed
More informationUNITED STATES DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE WASHINGTON, DC
UNITED STATES DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE WASHINGTON, DC FSIS DIRECTIVE 6000.1 Revision 1 8/3/06 RESPONSIBILITIES RELATED TO FOREIGN ANIMAL DISEASES (FADs) AND REPORTABLE
More informationWORLD ORGANIZATION FOR ANIMAL HEALTH /OIE/- ENGAGEMENT WITH ANIMAL WELFARE AND THE VETERINARY PROFFESSION
WORLD ORGANIZATION FOR ANIMAL HEALTH /OIE/- ENGAGEMENT WITH ANIMAL WELFARE AND THE VETERINARY PROFFESSION Prof. Dr. Nikola Belev Honorary President OIE Regional Commission for Europe Regional Representative
More informationSurveillance. Mariano Ramos Chargé de Mission OIE Programmes Department
Mariano Ramos Chargé de Mission OIE Programmes Department Surveillance Regional Table Top Exercise for Countries of Middle East and North Africa Tunisia; 11 13 July 2017 Agenda Key definitions and criteria
More informationOIE PVS Pathway including Veterinary Education
OIE PVS Pathway including Veterinary Education OIE Global Conference on the Prudent Use of Antimicrobial Agents for Animals: International Solidarity to Fight against Antimicrobial Resistance Paris (France)
More informationOIE mission in the framework of One Health Focus on antimicrobial resistance (AMR)
Dr Rachid Bouguedour OIE Representative for North Africa OIE mission in the framework of One Health Focus on antimicrobial resistance (AMR) General Assembly of REEV-Med Hammamet, Tunisia 13 December 2017
More informationFood borne diseases: the focus on Salmonella
Food borne diseases: the focus on Salmonella Prof. Jaap A. Wagenaar, DVM, PhD Dept Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, NL Central Veterinary
More informationBIORISK: AFRICAN EXPERIENCE
BIORISK: AFRICAN EXPERIENCE Mehdi EL HARRAK OIE BIOLOGICAL STANDARD COMMISION MEMBER Elharrak_m@hotmail.com 12 th OIE/WAVLD Seminar 9 June 2017, Sorrento Italy Africa : a major source of animal proteins
More informationOIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report h been submitted : 2017-01-11 18:55:37 Name of disee (or topic) for which you are a designated OIE Reference Laboratory: Brucellosis
More informationANIMAL HEALTH STANDARDS AND INTERNATIONAL TRADE
Dr. B.M. Modisane* Dr F. Cipriano** Dr. N. J. Mapitse** *OIE Delegate of South Africa **OIE Sub-Regional Representation for Southern Africa ANIMAL HEALTH STANDARDS AND INTERNATIONAL TRADE SADC REGIONAL
More informationOIE International Solidarity: General Overview
Dr. Alain Dehove (OIE) Coordinator of the World Animal Health and Welfare Fund OIE International Solidarity: General Overview Need for better Veterinary Governance 1 Second Global Conference of OIE Reference
More informationGarin-Bastuji. In terms of research and development, the work of the Unit concerns:
The Unit headed by Dr. GARIN-BASTUJI is dealing with the bacterial diseases of animals with a high level of risk for (human) public health and with a high economical incidence in livestock (Anthrax, Brucellosis,
More informationWageningen Bioveterinary Research. Biomedical and veterinary research to safeguard animal and public health
Wageningen Bioveterinary Research Biomedical and veterinary research to safeguard animal and public health Veterinary research to safeguard animal and public health Wageningen Bioveterinary Research (WBVR)
More information( ) Page: 1/6 COMMUNICATION FROM THE WORLD ORGANISATION FOR ANIMAL HEALTH (OIE)
14 October (16-5561) Page: 1/6 Committee on Sanitary and Phytosanitary Measures Original: English/French/Spanish 67 TH MEETING OF THE SPS COMMITTEE COMMUNICATION FROM THE WORLD ORGANISATION FOR ANIMAL
More informationAnimal Welfare: the role of the OIE
Animal Welfare: the role of the OIE Dr Sarah Kahn Director, International Trade Department Animal Welfare in Europe: Achievements and Future Prospects Strasbourg, 23-24 November 2006 CONTENTS Introduction
More informationWorld Organization for Animal Health
Veterinary Services World Organization for Animal Health Michael David MS, VMD, MPH National Import and Export Services International Animal Health Standards Services Information presented to the World
More informationANNEX. to the COMMISSION IMPLEMENTING DECISION
EUROPEAN COMMISSION Brussels, 30.4.2015 C(2015) 3024 final ANNEX 1 ANNEX to the COMMISSION IMPLEMENTING DECISION on the adoption of the multiannual work programme for 2016-2017 for the implementation of
More informationOIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)
OIE Regional Commission for Europe Regional Work Plan Framework 2017-2020 Version adopted during the 85 th OIE General Session (Paris, May 2017) Chapter 1 - Regional Directions 1.1. Introduction The slogan
More informationThe OIE s Codes, Manuals and associated standards
The OIE s Codes, Manuals and associated standards Standard setting implementation and mechanisms used Participation of Member countries Training Seminar for OIE Delegates from Europe Lyon, 5-6 November
More informationGeneral presentation of the OIE
General presentation of the OIE Regional Seminar for OIE National Focal Points for Animal Production Food Safety Belgrade, Serbia, 15 17 October, 2013 Dr N. Leboucq OIE Sub-Regional Representation in Brussels
More informationPromoting One Health : the international perspective OIE
Promoting One Health : the international perspective OIE Integrating Animal Health & Public Health: Antimicrobial Resistance SADC SPS Training Workshop (Animal Health) 29-31 January 2014 Gaborone, Botwana
More informationActivities of OIE on Zoonoses and Food- borne Diseases in the Asia-Pacific Region
Activities of OIE on Zoonoses and Food- borne Diseases in the Asia-Pacific Region APHCA-OIE Regional Workshop on Zoonoses, Food-borne Diseases and Antimicrobial Resistance Thimphu, Bhutan, 24 25 September
More informationTerrestrial and Aquatic Manuals and mechanism of standard adoption
Regional Seminar OIE National Focal Points for Veterinary Products Tokyo, Japan 2 4 March 2016 Terrestrial and Aquatic Manuals and mechanism of standard adoption Dr Maria Szabo Scientific and Technical
More informationOIE Reference Centres : General Overview
OIE Reference Centres : General Overview Training workshop on OIE standards for collection and shipping of pathological specimens Nairobi, KENYA 9-11 August 2011 1 Reference Laboratories and Collaborating
More informationRecommendations of the 3 rd OIE Global Conference on Animal Welfare
Recommendations of the 3 rd OIE Global Conference on Animal Welfare Seminar for OIE National Focal Points for Animal Welfare Seoul, Republic of Korea, 27 29 August 2013 Dr Tomoko Ishibashi OIE Regional
More informationRisk analysis : extent, compliance with OIE guidelines and case studies from Africa
Patrick Bastiaensen Programme Officer Sub-Regional Representation for Eastern Africa World Organisation for Animal Health Risk analysis : extent, compliance with OIE guidelines and case studies from Africa
More informationOIE standards relevant to international horse movement
OIE standards relevant to international horse movement Susanne Münstermann Scientific and Technical Department, OIE Paris Regional Conference for the Middle East and North Africa Dubai, 29September - 1
More informationOIE Terrestrial Animal Health Standards Commission Issues of interest to the region Challenges and proposals
OIE Terrestrial Animal Health Standards Commission Issues of interest to the region Challenges and proposals 26 th Conference of the OIE Regional Commission for Europe Bern, Switzerland, 22-26 September
More informationZoonoses: Austria Dr. Ulrich Herzog World Health Day Foodsafety AGES
Zoonoses: Austria 2005-2014 Dr. Ulrich Herzog World Health Day 2015 - Foodsafety 07.04.2015 - AGES Overview Legal Background - EU / Austria Development in Austria Outlook challenges for the future Summary
More informationGuidance Document. Alpacas and Llamas. 9 February 2018
Guidance Document Alpacas and Llamas 9 February 2018 Ministry for Primary Industries Standards Animal & Animal Products PO Box 2526, Wellington 6140 animalimports@mpi.govt.nz Contents Foreword 1 Contact
More informationCONTENTS. Introduction Section 1 - Zoonotic diseases in human Section 2 - Animal population... 5
CONTENTS Introduction... 1 Section 1 - Zoonotic diseases in human... 3 Section 2 - Animal population... 5 Section 3 - Veterinarians and veterinary para-pressionals... 11 Section 4 - National reference
More informationCollection of quantitative data on the use of antimicrobial agents including the establishment of an OIE database
Collection of quantitative data on the use of antimicrobial agents including the establishment of an OIE database OIE Regional Workshop for OIE National Focal Points for Veterinary Products Tokyo, Japan
More information